CD274 and head and neck squamous cell carcinoma: In our study, two different anti‐PD‐L1 assays (laboratory developed SP142 assay and 28‐8 complementary diagnostic assay used for head and neck squamous cell carcinoma) were used in 2 different groups of cases, respectively.